Surrey researchers Sign in
The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia
Journal article   Peer reviewed

The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia

E Hatzimichael, A Dasoula, R Shah, N Syed, A Papoudou-Bai, HM Coley, G Dranitsaris, KL Bourantas, J Stebbing and T Crook
EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.84(1), pp.47-51
01/01/2010

Abstract

Science & Technology Life Sciences & Biomedicine Hematology HEMATOLOGY multiple myeloma plasma cell neoplasia methylation EGLN1 EGLN3 prolyl-hydroxylase MULTIPLE-MYELOMA TUMOR-SUPPRESSOR CANCER HYPOXIA DISEASE GROWTH FAMILY GENE HIF
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272653800005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

Details

Usage Policy